Aduro Biotech CVR
13F holders, Q1 2024 (March 31)2holders
$0.00avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Aduro Biotech CVR in their 13F filings. The largest holders were Rhumbline Advisers ($0) and Erste Asset Management GmbH ($0).
- Company
- Aduro Biotech CVR
- CUSIP
- 007CVR012
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | No change | 14,713 | $0 |
| Erste Asset Management GmbH | 0.00% | No change | 185,269 | $0 |
"% of holder's portfolio" is ADURO BIOTECH CVR's weight in each manager's 13F, not the share of Aduro Biotech CVR the manager owns.